Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor: reply.

Autor:	Gerrits AJ; Center for Platelet Research Studies, Division of Hematology/Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Jakubowski JA; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA., Michelson AD; Center for Platelet Research Studies, Division of Hematology/Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Frelinger AL 3rd; Center for Platelet Research Studies, Division of Hematology/Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Jazyk:	angličtina
Zdroj:	Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2018 Mar; Vol. 16 (3), pp. 607-608. Date of Electronic Publication: 2018 Jan 29.
DOI:	10.1111/jth.13939
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text